Patent ID: 9494600
Filing Date: 2016-11-15
CPC Classification: C07K,G01N

Claim Text:
1. A test method for determining a lesion site of nephritis, comprising the following steps: (1) a step of measuring the concentrations of two or three of (i) total Fibroblast-Specific Protein 1 (FSP1), (ii) monomer FSP1, and (iii) multimer FSP1 in a biological sample derived from a test subject, (2) a step of comparing the concentration of monomer FSP1 and the concentration of multimer FSP1 of the biological sample derived from the test subject (3) a step of determining that a lesion site of nephritis is glomerulus when FSP1 is dominantly present as a monomer type in the biological sample derived from the test subject, and, conversely, when FSP1 is dominantly present as a multimer type in the sample, the lesion site of nephritis is interstitial tissue.